Various therapeutic proteins

The term "Various therapeutic proteins" is a non-specific, collective classification used to describe a broad range of protein-based drugs, including monoclonal antibodies, cytokines, enzymes, and hormones (Leader et al., 2008, Nature Reviews Drug Discovery). Unlike a specific molecular target such as a receptor or enzyme, this term represents a diverse class of biologics that function through various mechanisms, such as replacing a deficient protein, augmenting an existing pathway, or interfering with a specific molecule (FDA, "Therapeutic Protein Product Classification"). Because it encompasses a wide variety of entities, it does not have a single biological function or a specific role in a single disease state. Instead, therapeutic proteins are used across nearly all medical specialties to treat conditions ranging from diabetes and growth hormone deficiency to complex cancers and inflammatory diseases (Lagassé et al., 2017, F1000Research). In the context of target identification, this entry is considered incorrect or overly broad because it lacks the specificity required to define a unique drug-target interaction. Consequently, it cannot be associated with a singular set of biomarkers or a specific safety profile beyond general concerns like immunogenicity (NIH, "Biologics and Biosimilars"). This classification is often encountered in legacy databases where biologics are grouped together rather than mapped to their individual molecular targets.

Other names

Therapeutic proteinsBiologicsProtein therapeuticsBiopharmaceutical proteins

Not applicable as this is a broad category of molecules rather than a specific drug target.